CHF52.20
0.97%
SIX Swiss Exchange, Sep 17, 05:31 pm CEST. Closed.
ISIN
CH0038389992
Symbol
BION

BB Biotech Target price 2026 - Analyst rating & recommendation

BB Biotech Classifications & Recommendation

Buy
89%
Hold
11%

BB Biotech Price Target

Target Price CHF71.89
Price CHF52.20
Potential
Number of Estimates 5
5 Analysts have issued a price target BB Biotech 2027 . The average BB Biotech target price is CHF71.89. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 8 Analysts recommend BB Biotech to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BB Biotech stock has an average upside potential 2027 of . Most analysts recommend the BB Biotech stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million CHF 616.74 652.29
449.48% 5.76%
Net Margin 93.74% 30.76%
38.62% 67.19%

4 Analysts have issued a sales forecast BB Biotech 2026 . The average BB Biotech sales estimate is

CHF652m
unlock
. This is
31.17% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF1.3b 41.72%
unlock
, the lowest is
CHF0.0 100.00%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 CHF617m 449.48%
2026
CHF652m 5.76%
unlock
2027
CHF652m 0.00%
unlock
2028
CHF652m 0.00%
unlock

5 BB Biotech Analysts have issued a net profit forecast 2026. The average BB Biotech net profit estimate is

CHF201m
unlock
. This is
85.13% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF506m 62.52%
unlock
, the lowest is
CHF-32.9m 102.44%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CHF578m 661.70%
2026
CHF201m 65.30%
unlock
2027
CHF38.2m 80.95%
unlock
2028
CHF33.2m 13.24%
unlock

Net Margin

2025 93.74% 38.62%
2026
30.76% 67.19%
unlock
2027
5.86% 80.95%
unlock
2028
5.08% 13.31%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share CHF 10.54 3.64
663.77% 65.46%
P/E 14.20
EV/Sales negative

5 Analysts have issued a BB Biotech forecast for earnings per share. The average BB Biotech EPS is

CHF3.64
unlock
. This is
85.12% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
CHF9.18 62.47%
unlock
, the lowest is
CHF-0.60 102.45%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CHF10.54 663.77%
2026
CHF3.64 65.46%
unlock
2027
CHF0.69 81.04%
unlock
2028
CHF0.60 13.04%
unlock

P/E ratio

Current 2.11 148.03%
2026
14.20 571.81%
unlock
2027
74.54 424.93%
unlock
2028
85.91 15.25%
unlock

Based on analysts' sales estimates for 2026, the BB Biotech stock is valued at an EV/Sales of

-0.38
unlock
and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -0.26
2026
-0.38 46.35%
unlock
2027
-0.38 0.00%
unlock
2028
-0.38 0.00%
unlock

P/S ratio

Current
2026
4.34 45.27%
unlock
2027
4.34 0.00%
unlock
2028
4.34 0.00%
unlock

Current BB Biotech Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
PARETO SECURITIES AS
Locked
Locked
Locked Jun 23 2026
ODDO BHF
Locked
Locked
Locked Jun 22 2026
ODDO BHF
Locked
Locked
Locked Jan 23 2026
ODDO BHF
Locked
Locked
Locked Jan 22 2026
ODDO BHF
Locked
Locked
Locked Oct 24 2025
PARETO SECURITIES AS
Locked
Locked
Locked Sep 01 2025
ODDO BHF
Locked
Locked
Locked Jul 25 2025
Analyst Rating Date
Locked
PARETO SECURITIES AS:
Locked
Locked
Jun 23 2026
Locked
ODDO BHF:
Locked
Locked
Jun 22 2026
Locked
ODDO BHF:
Locked
Locked
Jan 23 2026
Locked
ODDO BHF:
Locked
Locked
Jan 22 2026
Locked
ODDO BHF:
Locked
Locked
Oct 24 2025
Locked
PARETO SECURITIES AS:
Locked
Locked
Sep 01 2025
Locked
ODDO BHF:
Locked
Locked
Jul 25 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today